2 active not recruiting, 2 not yet recruiting, 2 recruiting, 1 completed. 1 Early Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Active not recruiting 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Transplant Recipient (Kidney): new trials by email Literature Review of Transplant Recipient (Kidney) trials Research Report on Transplant Recipient (Kidney)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immune Monitoring-Guided Individualized Tacrolimus Therapy in Renal Transplant Recipients: An Observational Study and PK/PD Modeling No interventional treatment, only observational data collection without clinical drug adjustment - Transplant Recipient (Kidney) | Not yet recruiting | Zhongnan Hospital | 50 | 2026-09-01 | 2026-09-11 | |
| Study on Precision Dosing Strategies of Anti-infective Agents in the Very Early Stage of Kidney Transplantation Transplant Recipient (Kidney) | Not yet recruiting | Zhongnan Hospital | 40 | 2026-08-25 | 2026-08-14 | |
| Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus Tacrolimus - Kidney Disease, Chronic, Transplant Recipient (Kidney) | Phase 4 | Recruiting | Instituto de Investigación Hospital Universitario La Paz | 114 | 2025-06-02 | 2025-09-11 |
| Tolerance Through Mixed Chimerism (Sip-Tego) Combined Kidney/Bone Marrow Transplant, Donation of Kidney / Bone Marrow, Conditioning Regimen (Rituxan, Siplizumab (or ATGAM), Cyclophosphamide, Tegoprubart) - Kidney Failure, Transplant Recipient (Kidney) | Early Phase 1 | Active not recruiting | Tatsuo Kawai, MD, PhD | 12 | 2025-05-31 | 2026-09-25 |
| Clinical and Immunological Outcomes of Living and Deceased Donor Transplantation Transplant Recipient (Kidney) | Recruiting | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1293 | 2024-11-01 | 2025-01-06 | |
| Posttranslationally Modified Fetuin-A in Urine as a Marker for Renal Dysfunction (Patients With Chronic Kidney Disease - With or Without Kidney Transplantation). uPTM-FeA - Transplant Recipient (Kidney), Primary Kidney Transplantation | Unknown | University Hospital, Martin | 86 | 2024-06-25 | 2025-04-30 | |
| Developing a Health Literacy Intervention for Immigrant Kidney Transplant Recipients Health literacy intervention - Transplant Recipient (Kidney) | Active not recruiting | Oslo University Hospital | 20 | 2024-03-01 | 2025-03-05 | |
| Studies of Kidney Transplant Outcome Steroid-Free Maintenance Immunosuppression, Infection After Kidney Transplantation, Evaluation of the DGF nomogram in Thymoglobulin - Transplant Recipient (Kidney), Steroid-Free Maintenance Immunosuppression | Completed | University of Minnesota | 7500 | 2009-05-01 | 2019-05-15 |
Acute Kidney Injury (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Renal Insufficiency (2) · Chronic Disease (1) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Antilymphocyte Serum (1) · Cyclophosphamide (1) · Immunosuppression Therapy (1) · Rituximab (1) · Tacrolimus (1) · Transplantation (1) · Transplantation Conditioning (1) · siplizumab (1) · thymoglobulin (1)
Zhongnan Hospital (2) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · Instituto de Investigación Hospital Universitario La Paz (1) · Oslo University Hospital (1) · Tatsuo Kawai, MD, PhD (1) · University Hospital, Martin (1) · University of Minnesota (1)
United States (2) · Italy (1) · Norway (1) · Slovakia (1) · Spain (1)
Arthur Matas, MD (1) · Giorgia Comai, MD (1) · Tatsuo Kawai, MD PhD (1)